155 related articles for article (PubMed ID: 15516695)
1. Involvement of NADPH in the interaction between heme oxygenase-1 and cytochrome P450 reductase.
Higashimoto Y; Sakamoto H; Hayashi S; Sugishima M; Fukuyama K; Palmer G; Noguchi M
J Biol Chem; 2005 Jan; 280(1):729-37. PubMed ID: 15516695
[TBL] [Abstract][Full Text] [Related]
2. Protein/protein interactions in the mammalian heme degradation pathway: heme oxygenase-2, cytochrome P450 reductase, and biliverdin reductase.
Spencer AL; Bagai I; Becker DF; Zuiderweg ER; Ragsdale SW
J Biol Chem; 2014 Oct; 289(43):29836-58. PubMed ID: 25196843
[TBL] [Abstract][Full Text] [Related]
3. Structural basis for the electron transfer from an open form of NADPH-cytochrome P450 oxidoreductase to heme oxygenase.
Sugishima M; Sato H; Higashimoto Y; Harada J; Wada K; Fukuyama K; Noguchi M
Proc Natl Acad Sci U S A; 2014 Feb; 111(7):2524-9. PubMed ID: 24550278
[TBL] [Abstract][Full Text] [Related]
4. Mass spectrometric identification of lysine residues of heme oxygenase-1 that are involved in its interaction with NADPH-cytochrome P450 reductase.
Higashimoto Y; Sugishima M; Sato H; Sakamoto H; Fukuyama K; Palmer G; Noguchi M
Biochem Biophys Res Commun; 2008 Mar; 367(4):852-8. PubMed ID: 18194664
[TBL] [Abstract][Full Text] [Related]
5. The reactions of heme- and verdoheme-heme oxygenase-1 complexes with FMN-depleted NADPH-cytochrome P450 reductase. Electrons required for verdoheme oxidation can be transferred through a pathway not involving FMN.
Higashimoto Y; Sato H; Sakamoto H; Takahashi K; Palmer G; Noguchi M
J Biol Chem; 2006 Oct; 281(42):31659-67. PubMed ID: 16928691
[TBL] [Abstract][Full Text] [Related]
6. Global effects of the energetics of coenzyme binding: NADPH controls the protein interaction properties of human cytochrome P450 reductase.
Grunau A; Paine MJ; Ladbury JE; Gutierrez A
Biochemistry; 2006 Feb; 45(5):1421-34. PubMed ID: 16445284
[TBL] [Abstract][Full Text] [Related]
7. Crystal structure of a NADPH-cytochrome P450 oxidoreductase (CYPOR) and heme oxygenase 1 fusion protein implies a conformational change in CYPOR upon NADPH/NADP
Sugishima M; Sato H; Wada K; Yamamoto K
FEBS Lett; 2019 Apr; 593(8):868-875. PubMed ID: 30883732
[TBL] [Abstract][Full Text] [Related]
8. Crystal structure of heme oxygenase-1 from cyanobacterium Synechocystis sp. PCC 6803 in complex with heme.
Sugishima M; Migita CT; Zhang X; Yoshida T; Fukuyama K
Eur J Biochem; 2004 Nov; 271(22):4517-25. PubMed ID: 15560792
[TBL] [Abstract][Full Text] [Related]
9. Reduction of oxaporphyrin ring of CO-bound α-verdoheme complexed with heme oxygenase-1 by NADPH-cytochrome P450 reductase.
Sato H; Higashimoto Y; Sakamoto H; Sugishima M; Shimokawa C; Harada J; Palmer G; Noguchi M
J Inorg Biochem; 2011 Feb; 105(2):289-96. PubMed ID: 21194630
[TBL] [Abstract][Full Text] [Related]
10. The iron chaperone poly(rC)-binding protein 2 forms a metabolon with the heme oxygenase 1/cytochrome P450 reductase complex for heme catabolism and iron transfer.
Yanatori I; Richardson DR; Toyokuni S; Kishi F
J Biol Chem; 2017 Aug; 292(32):13205-13229. PubMed ID: 28655775
[TBL] [Abstract][Full Text] [Related]
11. Design of metal cofactors activated by a protein-protein electron transfer system.
Ueno T; Yokoi N; Unno M; Matsui T; Tokita Y; Yamada M; Ikeda-Saito M; Nakajima H; Watanabe Y
Proc Natl Acad Sci U S A; 2006 Jun; 103(25):9416-21. PubMed ID: 16769893
[TBL] [Abstract][Full Text] [Related]
12. Expression and characterization of full-length human heme oxygenase-1: the presence of intact membrane-binding region leads to increased binding affinity for NADPH cytochrome P450 reductase.
Huber WJ; Backes WL
Biochemistry; 2007 Oct; 46(43):12212-9. PubMed ID: 17915953
[TBL] [Abstract][Full Text] [Related]
13. Heme oxygenase isoforms differ in their subcellular trafficking during hypoxia and are differentially modulated by cytochrome P450 reductase.
Linnenbaum M; Busker M; Kraehling JR; Behrends S
PLoS One; 2012; 7(4):e35483. PubMed ID: 22545110
[TBL] [Abstract][Full Text] [Related]
14. Coupling of Redox and Structural States in Cytochrome P450 Reductase Studied by Molecular Dynamics Simulation.
Iijima M; Ohnuki J; Sato T; Sugishima M; Takano M
Sci Rep; 2019 Jun; 9(1):9341. PubMed ID: 31249341
[TBL] [Abstract][Full Text] [Related]
15. Identification of danthron as an isoform-specific inhibitor of HEME OXYGENASE-1/cytochrome P450 reductase interaction with anti-tumor activity.
Chou YT; Hsu FF; Hu DY; Chen YC; Hsu YH; Hsu JT; Chau LY
J Biomed Sci; 2018 Jan; 25(1):6. PubMed ID: 29361943
[TBL] [Abstract][Full Text] [Related]
16. Trp-676 facilitates nicotinamide coenzyme exchange in the reductive half-reaction of human cytochrome P450 reductase: properties of the soluble W676H and W676A mutant reductases.
Gutierrez A; Doehr O; Paine M; Wolf CR; Scrutton NS; Roberts GC
Biochemistry; 2000 Dec; 39(51):15990-9. PubMed ID: 11123926
[TBL] [Abstract][Full Text] [Related]
17. The binding sites on human heme oxygenase-1 for cytochrome p450 reductase and biliverdin reductase.
Wang J; de Montellano PR
J Biol Chem; 2003 May; 278(22):20069-76. PubMed ID: 12626517
[TBL] [Abstract][Full Text] [Related]
18. A role for highly conserved carboxylate, aspartate-140, in oxygen activation and heme degradation by heme oxygenase-1.
Fujii H; Zhang X; Tomita T; Ikeda-Saito M; Yoshida T
J Am Chem Soc; 2001 Jul; 123(27):6475-84. PubMed ID: 11439033
[TBL] [Abstract][Full Text] [Related]
19. Conformational Equilibrium of NADPH-Cytochrome P450 Oxidoreductase Is Essential for Heme Oxygenase Reaction.
Sugishima M; Taira J; Sagara T; Nakao R; Sato H; Noguchi M; Fukuyama K; Yamamoto K; Yasunaga T; Sakamoto H
Antioxidants (Basel); 2020 Jul; 9(8):. PubMed ID: 32731542
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of cytochrome P450 1A2-mediated metabolism and production of reactive oxygen species by heme oxygenase-1 in rat liver microsomes.
Reed JR; Cawley GF; Backes WL
Drug Metab Lett; 2011 Jan; 5(1):6-16. PubMed ID: 20942796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
